Report overview
Anti-cancer insurance is a kind of critical illness insurance, and anti-cancer medical insurance is a kind of medical insurance. The biggest difference is that it will be compensated once a diagnosis is made, and the other is that only medical expenses related to cancer are reimbursed. Compared with the anti-cancer medical insurance, the anti-cancer insurance has a longer-term and lasting protection, and the rate is constant, so there is no need to worry about renewal. Therefore, my answer to the senior sister focused on the analysis of cancer prevention insurance. The coverage of cancer prevention insurance is much smaller than that of critical illness insurance. It only targets malignant tumors, but it can also cover the highest incidence of serious illnesses.
This report aims to provide a comprehensive presentation of the global market for Anti-cancer Insurance, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-cancer Insurance. This report contains market size and forecasts of Anti-cancer Insurance in global, including the following market information:
Global Anti-cancer Insurance Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Anti-cancer Insurance market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Benefit-based Anti-cancer Insurance Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-cancer Insurance include ACE Insurance, Achmea, AEGON, Allianz, Anadolu Hayat Emeklilik, Assicurazioni Generali, Assurant, AIA Group and AlfaStrakhovanie, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Anti-cancer Insurance companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-cancer Insurance Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Anti-cancer Insurance Market Segment Percentages, by Type, 2022 (%)
Benefit-based Anti-cancer Insurance
Reimbursable Anti-cancer Medical Insurance
Global Anti-cancer Insurance Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Anti-cancer Insurance Market Segment Percentages, by Application, 2022 (%)
People at the age of High Incidence of Cancer
Middle-aged and Elderly Over 50 Years Old
People with a Family History of Cancer
Others
Global Anti-cancer Insurance Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Anti-cancer Insurance Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-cancer Insurance revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti-cancer Insurance revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ACE Insurance
Achmea
AEGON
Allianz
Anadolu Hayat Emeklilik
Assicurazioni Generali
Assurant
AIA Group
AlfaStrakhovanie
Banamex
Banco Bilbao Vizcaya Argentaria
Banco Bradesco
BNP Paribas Cardif
China Life Insurance Company
China Pacific Insurance
CNP Assurances
Credit Agricole
DZ Bank
Garanti Emeklilik ve Hayat
Great Eastern Holdings
Grupo Nacional Provincial
Hanwha Life Insurance Company
HDFC Standard Life Insurance Company
ICICI Prudential Life Insurance Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-cancer Insurance, market overview.
Chapter 2: Global Anti-cancer Insurance market size in revenue.
Chapter 3: Detailed analysis of Anti-cancer Insurance company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-cancer Insurance in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
